Objective:

To determine the impact of the implementation of an influen za vaccination campaign in a hospital pharmacy service on patients who are starting or receiving treatment with biological therapies.

Method:

A 15-month quasi-experimental study of patients starting or receiving treatment with biological therapies. Between October and De cember 2016 and October and December 2017, we compared influenza vaccination rates, the incidence of influenza in the study population, the direct impact of the vaccination campaign on the patient, the effect of the campaign on vaccination rates, and the results of the satisfaction survey.

Results:

A total of 188 patients participated in the study. Of the pa tients who had not been vaccinated in the 2016/2017 campaign, 72.6% were vaccinated (p < 0.000) during the 2017/2018 campaign. No sta tistically significant differences were found between the 2016/2017 and 2017/2018 campaign (p = 0.636) in the percentage of patients who contracted flu after receiving the vaccine. In total, 99.5% thought that the campaign was a good initiative, and 50.5% reported that their decision to be vaccinated was influenced by the fact that the campaign was led by the hospital pharmacy service.

Conclusions:

The implementation of the influenza vaccination cam paign in the hospital pharmacy service achieved led to a marked increa se in vaccination rates. This result underlines the key role played by the hospital pharmacy service in achieving this level of success.

        · abstract in Spanish     · text in English | Spanish     · English ( pdf ) | Spanish ( pdf )